Resources

Filter by:

Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee

Samuelson Bannow B, Federspiel JJ, Abel DE, Mauney L, Rosovsky RP, Bates SM.
Guidelines LAN Developed Pregnancy and Postpartum

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Ragni MV, Rothenberger SD, Feldman R, Nance D, Leavitt AD, Malec L, Kulkarni R, Sidonio R Jr, Kraut E, Lasky J, Pruthi R, Angelini D, Philipp C, Hwang N, Wheeler AP, Seaman C, Machin N, Xavier F, Meyer M, Bellissimo D, Humphreys G, Smith KJ, Merricks EP, Nichols TC, Ivanco D, Vehec D, Koerbel G, Althouse AD.
Heavy menstrual bleeding Von Willebrand Disease

Menstrual Technology Innovations and the Implications for Heavy Menstrual Bleeding

Liberty, A., Samuelson Bannow, B., Matteson, K., Edelman, A., & Colwill, A.
Heavy menstrual bleeding

Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018

Early, M. L., Eke, A. C., Gemmill, A., Lanzkron, S., & Pecker, L. H.
Sickle Cell Disease

Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies and anemias

Baldwin MK, Bannow BS, Rosovsky RP, Sokkary N, Srivaths L
Anemias Clotting & Clotting Disorders LAN Developed Platelets

Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety

Leminen, H., & Hurskainen, R.